These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 32143307)
21. Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and Survival. Gu CD; Osaki T; Oyama T; Inoue M; Kodate M; Dobashi K; Oka T; Yasumoto K Ann Surg; 2002 Jan; 235(1):133-9. PubMed ID: 11753052 [TBL] [Abstract][Full Text] [Related]
22. Lymph Node Micrometastasis Prognosticates Survival for Patients with Stage 1 Bronchogenic Adenocarcinoma. Ren Y; Zhang L; Xie H; She Y; Su H; Xie D; Zheng H; Zhang L; Jiang G; Wu C; Dai C; Chen C Ann Surg Oncol; 2018 Dec; 25(13):3812-3819. PubMed ID: 30203406 [TBL] [Abstract][Full Text] [Related]
23. Prognostic value of nodal micrometastases in patients with cancer of the gastro-oesophageal junction. Heeren PA; Kelder W; Blondeel I; van Westreenen HL; Hollema H; Plukker JT Eur J Surg Oncol; 2005 Apr; 31(3):270-6. PubMed ID: 15780562 [TBL] [Abstract][Full Text] [Related]
24. Detection of micrometastases in pN0 non-small cell lung cancer: an alternative method combining tissue microarray and immunohistochemistry. Franco MR; Parra ER; Takagaki TY; Soares FA; Capelozzi VL J Bras Pneumol; 2008 Mar; 34(3):129-35. PubMed ID: 18392460 [TBL] [Abstract][Full Text] [Related]
26. Mode of spread in the early phase of lymphatic metastasis in non-small-cell lung cancer: significance of nodal micrometastasis. Izbicki JR; Passlick B; Hosch SB; Kubuschock B; Schneider C; Busch C; Knoefel WT; Thetter O; Pantel K J Thorac Cardiovasc Surg; 1996 Sep; 112(3):623-30. PubMed ID: 8800148 [TBL] [Abstract][Full Text] [Related]
27. Sentinel node mapping and micrometastasis in patients with clinical stage IA non-small cell lung cancer. Ono T; Minamiya Y; Ito M; Saito H; Motoyama S; Nanjo H; Ogawa J Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):659-61. PubMed ID: 19643803 [TBL] [Abstract][Full Text] [Related]
28. Detection of CEA mRNA, p53 and AE1/AE3 in haematoxylin-eosin-negative lymph nodes of early-stage non-small cell lung cancer may improve veracity of N staging and indicate prognosis. Qiu Y; Yang H; Chen H; Ge L; Xu X; Xiong X; He J Jpn J Clin Oncol; 2010 Feb; 40(2):146-52. PubMed ID: 19897851 [TBL] [Abstract][Full Text] [Related]
29. Lymph node micrometastases do not predict relapse in stage II colon cancer. Tschmelitsch J; Klimstra DS; Cohen AM Ann Surg Oncol; 2000 Sep; 7(8):601-8. PubMed ID: 11005559 [TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy. Braun S; Cevatli BS; Assemi C; Janni W; Kentenich CR; Schindlbeck C; Rjosk D; Hepp F J Clin Oncol; 2001 Mar; 19(5):1468-75. PubMed ID: 11230493 [TBL] [Abstract][Full Text] [Related]
31. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with gallbladder carcinoma. Sasaki E; Nagino M; Ebata T; Oda K; Arai T; Nishio H; Nimura Y Ann Surg; 2006 Jul; 244(1):99-105. PubMed ID: 16794394 [TBL] [Abstract][Full Text] [Related]
32. Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients. Querzoli P; Pedriali M; Rinaldi R; Lombardi AR; Biganzoli E; Boracchi P; Ferretti S; Frasson C; Zanella C; Ghisellini S; Ambrogi F; Antolini L; Piantelli M; Iacobelli S; Marubini E; Alberti S; Nenci I Clin Cancer Res; 2006 Nov; 12(22):6696-701. PubMed ID: 17121888 [TBL] [Abstract][Full Text] [Related]
33. Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients--prognostic relevance after 10 years. Gebauer G; Fehm T; Merkle E; Jaeger W; Mitze M Anticancer Res; 2003; 23(5b):4319-24. PubMed ID: 14666645 [TBL] [Abstract][Full Text] [Related]
34. Hamburg-Glasgow classification: preoperative staging by combination of disseminated tumour load and systemic inflammation in oesophageal carcinoma. Reeh M; Ghadban T; Uzunoglu FG; Nentwich MF; Bockhorn M; Pantel K; Izbicki JR; Vashist YK Br J Cancer; 2017 Aug; 117(5):612-618. PubMed ID: 28704837 [TBL] [Abstract][Full Text] [Related]
35. Disseminated tumor cells in bone marrow and the natural course of resected esophageal cancer. Vashist YK; Effenberger KE; Vettorazzi E; Riethdorf S; Yekebas EF; Izbicki JR; Pantel K Ann Surg; 2012 Jun; 255(6):1105-12. PubMed ID: 22580852 [TBL] [Abstract][Full Text] [Related]
36. Occurrence and prognostic implications of micrometastases in lymph nodes from patients with submucosal gastric carcinoma. Choi HJ; Kim YK; Kim YH; Kim SS; Hong SH Ann Surg Oncol; 2002; 9(1):13-9. PubMed ID: 11829425 [TBL] [Abstract][Full Text] [Related]
37. DETECTION OF OCCULT LYMPH NODE TUMOR CELLS IN NODE-NEGATIVE GASTRIC CANCER PATIENTS. Pereira MA; Ramos MFKP; Dias AR; Yagi OK; Faraj SF; Zilberstein B; Cecconello I; Mello ES; Ribeiro U Arq Bras Cir Dig; 2017; 30(1):30-34. PubMed ID: 28489165 [TBL] [Abstract][Full Text] [Related]
38. Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance. Hosch SB; Stoecklein NH; Pichlmeier U; Rehders A; Scheunemann P; Niendorf A; Knoefel WT; Izbicki JR J Clin Oncol; 2001 Apr; 19(7):1970-5. PubMed ID: 11283129 [TBL] [Abstract][Full Text] [Related]
39. Lymph node, peritoneal and bone marrow micrometastases in gastric cancer: Their clinical significance. Griniatsos J; Michail O; Dimitriou N; Karavokyros I World J Gastrointest Oncol; 2012 Feb; 4(2):16-21. PubMed ID: 22403737 [TBL] [Abstract][Full Text] [Related]
40. Effect of lymph node micrometastases on prognosis of gastric carcinoma. Wu ZY; Li JH; Zhan WH; He YL; Wan J World J Gastroenterol; 2007 Aug; 13(30):4122-5. PubMed ID: 17696234 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]